These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 36773572)

  • 21. Targeting tumor-associated macrophages for cancer immunotherapy.
    Cao X; Lai SWT; Chen S; Wang S; Feng M
    Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Injectable shear-thinning polylysine hydrogels for localized immunotherapy of gastric cancer through repolarization of tumor-associated macrophages.
    Yang Y; Yang Y; Chen M; Chen J; Wang J; Ma Y; Qian H
    Biomater Sci; 2021 Sep; 9(19):6597-6608. PubMed ID: 34582523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage Polarization Contributes to the Anti-Tumoral Efficacy of Mesoporous Nanovectors Loaded with Albumin-Bound Paclitaxel.
    Leonard F; Curtis LT; Ware MJ; Nosrat T; Liu X; Yokoi K; Frieboes HB; Godin B
    Front Immunol; 2017; 8():693. PubMed ID: 28670313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy.
    Schweer D; McAtee A; Neupane K; Richards C; Ueland F; Kolesar J
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TAM-targeted reeducation for enhanced cancer immunotherapy: Mechanism and recent progress.
    Shen X; Zhou S; Yang Y; Hong T; Xiang Z; Zhao J; Zhu C; Zeng L; Zhang L
    Front Oncol; 2022; 12():1034842. PubMed ID: 36419877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
    Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
    Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy.
    Khan SU; Khan MU; Azhar Ud Din M; Khan IM; Khan MI; Bungau S; Hassan SSU
    Front Immunol; 2023; 14():1166487. PubMed ID: 37138860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma.
    Anand N; Peh KH; Kolesar JM
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational combination of an immune checkpoint inhibitor with CSF1R inhibitor-loaded nanoparticle enhances anticancer efficacy.
    Ramesh A; Malik V; Ranjani HA; Smith H; Kulkarni AA
    Drug Deliv Transl Res; 2021 Dec; 11(6):2317-2327. PubMed ID: 34365577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infiltration of Apoptotic M2 Macrophage Subpopulation Is Negatively Correlated with the Immunotherapy Response in Colorectal Cancer.
    Liu R; Han C; Hu J; Zhang B; Luo W; Ling F
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression.
    Pu Y; Ji Q
    Front Immunol; 2022; 13():874589. PubMed ID: 35592338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymersomes-Mediated Delivery of CSF1R Inhibitor to Tumor Associated Macrophages Promotes M2 to M1-Like Macrophage Repolarization.
    Rodriguez-Perdigon M; Jimaja S; Haeni L; Bruns N; Rothen-Rutishauser B; Rüegg C
    Macromol Biosci; 2022 Aug; 22(8):e2200168. PubMed ID: 35624036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour-Associated Macrophages (TAMs) in Colon Cancer and How to Reeducate Them.
    Yahaya MAF; Lila MAM; Ismail S; Zainol M; Afizan NARNM
    J Immunol Res; 2019; 2019():2368249. PubMed ID: 30931335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology.
    Vanmeerbeek I; Govaerts J; Laureano RS; Sprooten J; Naulaerts S; Borras DM; Laoui D; Mazzone M; Van Ginderachter JA; Garg AD
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance.
    Mola S; Pandolfo C; Sica A; Porta C
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Amino Acid Metabolism of Tumor Associated Macrophages in the Development of Colorectal Cancer.
    Jiang M; Cui H; Liu Z; Zhou X; Zhang L; Cao L; Wang M
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-associated macrophage polarization in the inflammatory tumor microenvironment.
    Zou Z; Lin H; Li M; Lin B
    Front Oncol; 2023; 13():1103149. PubMed ID: 36816959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting tumor-associated macrophages in the tumor microenvironment.
    Zhou K; Cheng T; Zhan J; Peng X; Zhang Y; Wen J; Chen X; Ying M
    Oncol Lett; 2020 Nov; 20(5):234. PubMed ID: 32968456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting tumor-associated macrophages as an antitumor strategy.
    Cheng N; Bai X; Shu Y; Ahmad O; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.
    Li X; Guo X; Ling J; Tang Z; Huang G; He L; Chen T
    Nanoscale; 2021 Mar; 13(9):4705-4727. PubMed ID: 33625411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.